Safety of the galactose-based ultrasound contrast agent levovist.
Schlief
Reinhard
R
Clinical Development Diagnostics and Corporate Drug Safety, Schering AG, Berlin, Germany.
Alhassan
Abudulai
A
Wiggins
Jay
J
Schumann
Wolfgang
W
Niendorf
Hans-Peter
HP
D000787:Angina Pectoris / Q000139:chemically induced; D001986:Bronchial Spasm / Q000139:chemically induced*; D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D011134:Polysaccharides / Q000009:adverse effects*; D014463:Ultrasonography / Q000379:methods; D014581:Urticaria / Q000139:chemically induced
D003287:Contrast Media; D011134:Polysaccharides; C059891:SHU 508